Respiratory medicine
Journal
Overview
publication venue for
-
Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24].
2017
-
Platelet activation and COPD-related clinical and imaging characteristics: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study..
241.
2025
-
Antinuclear antibodies and progression of quantitative interstitial lung changes: The Multi-Ethnic Study of Atherosclerosis (MESA)-Lung Study..
238.
2025
-
Exacerbation-like events in the 12 months prior to identification of chronic respiratory conditions in a primary care population..
231.
2024
-
Durable medication-free remission of sarcoidosis following discontinuation of anti-tumor necrosis factor-α therapy..
206.
2022
-
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis..
205.
2022
-
Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study..
197.
2022
-
Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial..
185.
2021
-
Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment..
176.
2020
-
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol..
158.
2019
-
Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosis..
152.
2019
-
Collagen biomarkers and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis..
140.
2018
-
NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort..
140.
2018
-
Sleep disturbance and symptom burden in sarcoidosis..
144S.
2018
-
Possible UIP pattern on high-resolution computed tomography is associated with better survival than definite UIP in IPF patients..
131.
2017
-
Frailty and maximal exercise capacity in adult lung transplant candidates..
131.
2017
-
Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial..
131.
2017
-
Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?.
122 Suppl 1.
2016
-
A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD..
120.
2016
-
Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling..
118.
2016
-
Hypersensitivity pneumonitis and antigen identification--An alternate approach..
112.
2015
-
Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients..
108.
2014
-
Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis..
108.
2013
-
The clinical impact of non-obstructive chronic bronchitis in current and former smokers..
108.
2013
-
One airway: Biomarkers of protection from upper and lower airway injury after World Trade Center exposure..
108.
2013
-
Genetic and environmental factors on the relation of lung function and arterial stiffness..
107.
2013
-
Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: a randomised trial..
107.
2013
-
Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial..
106.
2011
-
Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD..
105.
2011
-
Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ)..
104.
2010
-
Gender influences Health-Related Quality of Life in IPF..
104.
2009
-
Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series..
103.
2008
-
Does the relationship between asthma and obesity differ by neighborhood?.
102.
2008
-
Slow-onset asthma deaths have more eosinophils and health care utilization than rapid-onset deaths..
102.
2008
-
A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly..
102.
2008
-
Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis..
101.
2007
-
Comparison of induced sputum inflammatory profiles between childhood and adult-onset asthma..
100.
2006
-
Discordance between general and pulmonary pathologists in the diagnosis of interstitial lung disease..
99.
2005
-
Frequency, prevention, outcome and treatment of ventilator-associated tracheobronchitis: systematic review and meta-analysis.
2010
-
Moving towards a Treatable Traits model of care for the management of obstructive airways diseases.
2021
-
Elevated serum cardiac troponin and mortality in acute pulmonary embolism: Systematic review and meta-analysis.
2019
-
Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV1/FVC.
2019
-
Management of combined pre- and post-capillary pulmonary hypertension in advanced heart failure with reduced ejection fraction.
2017
-
Bronchiolitis obliterans organizing pneumonia in cancer: a case series.
2002
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)